Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001

  • STATUS
    Recruiting
  • End date
    Dec 30, 2021
  • participants needed
    70
  • sponsor
    Collaborative Medicinal Development Pty Limited
Updated on 22 March 2020
Investigator
Kay Noel, PhD
Primary Contact
Macquarie University (0.8 mi away) Contact

Summary

Provides up to six months treatment with CuATSM for subjects who have successfully completed study CMD-2019-001

Description

Provides up to six months treatment with CuATSM for subjects who have successffulyl completed study CMD-2019-001. [This allows subjects randomized to placebo on study CMD-2019-001 to receive up to six months treatment with CuATSM and provides an up to an additional six months treatment with CuATSM for subjects randomized to CuATSM on study CMD-2019-001]

Details
Treatment Cu(II)ATSM
Clinical Study IdentifierNCT04313166
SponsorCollaborative Medicinal Development Pty Limited
Last Modified on22 March 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Eligibility

Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 75 yrs?
Gender: Male or Female
Do you have any of these conditions: Amyotrophic Lateral Sclerosis or Myelopathy or Amyotrophic Lateral Sclerosis (ALS) or Spinal Cord Disorders?
signed informed consent prior to initiation of any study-specific procedures and treatment
documented completion of protocol-specified assessments following completion of 24 weeks treatment on study CMD-2019-002
Investigator considers patient has been tolerating treatment on study CMD-2019-001 and may benefit from continued treatment with CuATSM

Exclusion Criteria

not dependent on mechanical ventilation
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet